naftidrofuryl


Also found in: Wikipedia.

naftidrofuryl

An artery-widening drug used to improve the blood supply to the brain and to the limbs. A brand name is Praxilene.
References in periodicals archive ?
A randomized, double-blind study for the treatment of sudden deafness: low-molecular weight dextran and naftidrofuryl versus low-molecular weight dextran and placebo.
Stevens et al., "Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease," Angiology, vol.
NAFTIDROFURYL: is an antiplatelet drug which also blocks serotonin, improving oxygen absorption (Harvey, S., 2002) It may alleviate symptoms and increase pain free walking distance in moderate cases (Mehta, D.
They exceed the improvements reported for other conventional PAD drug therapies including pentoxifylline, cilostazol, dipyridamole, ticlopidine, beraprost, iloprost, naftidrofuryl, and statins, Dr.
Naftidrofuryl, 600 mg daily, is a 5-hydroxytryptamine type II inhibitor that improves muscle metabolism and prevents red-cell and platelet aggregation.
Patients with peripheral arterial disease (PAD) may find some pain relief by using a common medication, naftidrofuryl (Praxilene), a drug that relaxes blood vessels.
Some studies have shown that the medication Naftidrofuryl oxalate can make a little improvement.
After noting that calcium oxalate monohydrate crystalluria was higher in elderly patients, we undertook a study to determine if oral treatment with naftidrofuryl oxalate, a drug frequently prescribed for elderly patients in France, was associated with crystalluria.
TASC-II recommends a 3--to 6-month trial of pharmacotherapy with a vasoactive agent--cilostazol (Pletal) is the only one approved in the United States, and naftidrofuryl the sole European drug--as part of the initial therapy for IC.
Towards a model stroke trial: the single-centre naftidrofuryl study.
Agents found to be ineffective in randomized clinical trials include nifedipine, fish oil supplements, edetic acid chelation therapy, ketanserin, suloctidil, and naftidrofuryl.